| Dr Betsey Bergquist, PHARMD | |
|
4040 Martin Luther King Blvd, Ste B, North Las Vegas, NV 89032 | |
| (702) 625-6624 | |
| Not Available |
| Full Name | Dr Betsey Bergquist |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 4040 Martin Luther King Blvd, North Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083231906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 20396 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Betsey Bergquist, PHARMD 4040 Martin Luther King Blvd, Ste B, North Las Vegas, NV 89032 Ph: (702) 625-6624 | Dr Betsey Bergquist, PHARMD 4040 Martin Luther King Blvd, Ste B, North Las Vegas, NV 89032 Ph: (702) 625-6624 |
News Archive
When it comes to gene sequencing and personalized medicine for cancer, spotting an aberrant kinase is a home run. The proteins are relatively easy to target with drugs and plenty of kinase inhibitors already exist.
Applied Spine Technologies (www.appliedspine.com) announces the first patient surgery at Allegheny General Hospital in Pittsburgh, Pennsylvania, as part of their FDA approved Investigational Device Exemption (IDE) clinical trial designed to evaluate the safety and effectiveness of the Stabilimax® Dynamic Spine Stabilization System.
The Johns Hopkins Bloomberg School of Public Health today announced that its Department of International Health and International Injury Research Unit have been designated a "collaborating center" by the World Health Organization. The new WHO Collaborating Center for Injuries, Violence and Accident Prevention is only the third collaborating center in the United States to focus on injury prevention and joins a network of more than 800 WHO Collaborating Centers in more than 80 countries.
PointBreak trial results suggest that pemetrexed- and paclitaxel-based chemotherapy offer comparable survival outcomes and tolerability for patients with advanced nonsquamous non-small-cell lung cancer (NSCLC) but with differing toxicity profiles.
The class of immunotherapies known as checkpoint inhibitors have proven to be a highly effective and advantageous treatment option for many cancer patients, but they don't work well for everyone, and oncologists have no reliable way to determine in advance which patients are likely to respond to these drugs.
› Verified 6 days ago
Ted Turner, PHARM.D., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 Pecos Rd, North Las Vegas, NV 89086 Phone: 702-271-2895 | |
Hanna A Mekonnen, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4755 W Ann Rd, North Las Vegas, NV 89031 Phone: 702-645-1360 Fax: 702-396-8514 | |
Jenny Casiello, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Wyneisha Edwards, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1408 W Craig Rd, North Las Vegas, NV 89032 Phone: 702-642-2680 | |
Alvin Tseng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 N Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 | |
Mr. Bryan Lloyd Tarman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6900 Pecos Rd, North Las Vegas, NV 89086 Phone: 702-791-9000 Fax: 702-224-6902 | |
Dr. Andrea Danielle Hawkins, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1445 W Craig Rd, North Las Vegas, NV 89032 Phone: 702-649-3113 Fax: 702-649-3780 |